MoneyWorks4Me

Lupin - Quaterly Results

07 Nov 2025 Evaluate
The revenue for the September 2025 quarter is pegged at Rs. 40682.80 millions against Rs. 41062.00 millions recorded during the year-ago period.Handsome Net Profit growth of 68.04% reported above the corresponding previous quarter figure of Rs. 13573.50 millions to Rs. 8077.60 millions.The company reported a good operating profit of 12456.30 millions compared to 11473.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202509 202409 % Var 202509 202409 % Var 202503 202403 % Var
Sales 40682.80 41062.00 -0.92 97768.70 82738.30 18.17 169675.00 146665.00 15.69
Other Income 700.00 326.20 114.59 1241.40 708.40 75.24 1740.50 1067.30 63.08
PBIDT 12456.30 11473.70 8.56 40294.10 23852.60 68.93 56465.30 35657.90 58.35
Interest 277.80 175.50 58.29 466.80 311.00 50.10 845.00 563.50 49.96
PBDT 18105.30 11298.20 60.25 45754.10 23541.60 94.35 54848.10 35094.40 56.29
Depreciation 1747.20 1457.70 19.86 3514.50 2871.90 22.38 6476.90 7247.50 -10.63
PBT 16358.10 9840.50 66.23 42239.60 20669.70 104.36 48371.20 27846.90 73.70
TAX 2784.60 1762.90 57.96 7385.40 3700.30 99.59 8641.60 4586.00 88.43
Deferred Tax -87.70 43.40 -302.07 -2.30 88.90 -102.59 70.40 -254.50 -127.66
PAT 13573.50 8077.60 68.04 34854.20 16969.40 105.39 39729.60 23260.90 70.80
Equity 913.60 912.30 0.14 913.60 912.30 0.14 913.20 911.40 0.20
PBIDTM(%) 30.62 27.94 9.58 41.21 28.83 42.96 33.28 24.31 36.88
Peers
Company Name CMP
Sun Pharma. Inds. 1860.00
Dr. Reddys Labs. 1250.00
Cipla 1383.00
Lupin 2060.00
Zydus Lifesciences 1195.20
View more..